An overview of traditional Chinese medicine therapy for Helicobacter pylori–related gastritis

Helicobacter pylori–associated gastritis (HPAG) is a common digestive system disease that its therapeutic goal is to eradicate Helicobacter pylori. However, due to the widespread use of antibiotics, problems for example, antibiotic resistance, reinfection, and gastrointestinal side effects have emerged. The solution of above problems provides a broad space for traditional Chinese medicine (TCM) to exert its remarkable advantages on the treatment of HPAG.

[1]  Yanling Zhao,et al.  Berberine regulates macrophage polarization through IL-4-STAT6 signaling pathway in Helicobacter pylori-induced chronic atrophic gastritis. , 2020, Life sciences.

[2]  S. Regmi,et al.  Prevalence of Helicobacter Pylori in Endoscopic Gastric Biopsies of Chronic Gastritis Patients at A Tertiary Care Centre , 2020, JNMA; journal of the Nepal Medical Association.

[3]  Nguyen Dang Khoa Le,et al.  High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the South East area of Vietnam. , 2020, Journal of global antimicrobial resistance.

[4]  Rui-sheng Li,et al.  Palmatine ameliorates Helicobacter pylori-induced chronic atrophic gastritis by inhibiting MMP-10 through ADAM17/EGFR. , 2020, European journal of pharmacology.

[5]  Rui-sheng Li,et al.  Mechanism of berberine in treating Helicobacter pylori induced chronic atrophic gastritis through IRF8-IFN-γ signaling axis suppressing. , 2020, Life sciences.

[6]  Lingli Li,et al.  The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials , 2020, Frontiers in Pharmacology.

[7]  Q. Luo,et al.  Ultrastructure Characteristics of Different Chinese Medicine Syndromes of Helicobacter pylori-Correlated Gastric Diseases , 2019, Chinese Journal of Integrative Medicine.

[8]  Jai-Sing Yang,et al.  Baicalin, Baicalein, and Lactobacillus Rhamnosus JB3 Alleviated Helicobacter pylori Infections in Vitro and in Vivo. , 2018, Journal of food science.

[9]  Paola Bocanegra-Ibarias,et al.  Helicobacter pylori drug resistance: therapy changes and challenges , 2018, Expert review of gastroenterology & hepatology.

[10]  Yunfei Jia,et al.  Berberine demonstrates anti‐inflammatory properties in Helicobacter pylori‐infected mice with chronic gastritis by attenuating the Th17 response triggered by the B cell‐activating factor , 2018, Journal of cellular biochemistry.

[11]  Z. Zeng,et al.  Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection , 2017, Helicobacter.

[12]  Xiaoqing Xie,et al.  Quercetin from Polygonum capitatum Protects against Gastric Inflammation and Apoptosis Associated with Helicobacter pylori Infection by Affecting the Levels of p38MAPK, BCL-2 and BAX , 2017, Molecules.

[13]  Chui-jie Wang,et al.  [Efficacy of Chinese Medicine Combined with Fixed Quadruple Therapy on Hp Positive Chronic Gastritis]. , 2017, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[14]  Jianhui Xie,et al.  Comparison of Helicobacter pylori Urease Inhibition by Rhizoma Coptidis, Cortex Phellodendri and Berberine: Mechanisms of Interaction with the Sulfhydryl Group , 2015, Planta Medica.

[15]  P. Malfertheiner,et al.  Kyoto global consensus report on Helicobacter pylori gastritis , 2015, Gut.

[16]  Jian Huang,et al.  Flavonoid Glycosides of Polygonum capitatum Protect against Inflammation Associated with Helicobacter pylori Infection , 2015, PloS one.

[17]  Xiao-qiang Mo,et al.  Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance. , 2015, World journal of gastroenterology.

[18]  Jianhui Xie,et al.  Biological evaluation and molecular docking of baicalin and scutellarin as Helicobacter pylori urease inhibitors. , 2015, Journal of ethnopharmacology.

[19]  Wang Hong-bin.  Clinical study on Jianpi Qinghua Prescription combined with remedial method for the treatment of drugresistance helicobacter pylori-infected gastritis with the syndrome of spleen deficiency and damp-heat , 2015 .

[20]  Yu-Hsin Lin,et al.  Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study. , 2015, Nanomedicine.

[21]  K. Hahm,et al.  Special Licorice Extracts Containing Lowered Glycyrrhizin and Enhanced Licochalcone A Prevented Helicobacter pylori‐Initiated, Salt Diet‐Promoted Gastric Tumorigenesis , 2014, Helicobacter.

[22]  Yan-Qiang Huang.  Effects of emodin and other herbal extracts on resistance ofHelicobacter pylorito clarithromycin , 2014 .

[23]  L. Jing.  Treatment of Chronic Gastritis with Masculine HP by Combination of Traditional Chinese Medicine and Western Medicine , 2013 .

[24]  Yu-Hsin Lin,et al.  Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori. , 2011, Acta biomaterialia.

[25]  Y. Qi.  Effect of Serum Containing Astragalus on the Activity of Helicobacter Pylori VacA , 2011 .

[26]  Peng Xiaowei.  Inhibition effects of Chinese herbs on Helicobacter pylori in mice , 2010 .

[27]  H. Wen.  Study on Content Determination and Antibacterial Effects of Triterpenes from Sclerotia of Poria cocos , 2009 .

[28]  Dong Hu,et al.  [Study of Scutellaria baicalensis and Baicalin against antimicrobial susceptibility of Helicobacter pylori strains in vitro]. , 2008, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[29]  Qian Li,et al.  [Observation on the expression of PS2 and platelet activating factor affected by Jianwei Yuyang granules and study its potential mechanisim against peptic ulcer]. , 2007, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[30]  Chong-Zhi Wang,et al.  Scutellaria baicalensis and a constituent flavonoid, baicalein, attenuate ritonavir‐induced gastrointestinal side‐effects , 2007, The Journal of pharmacy and pharmacology.

[31]  You Jiang-feng.  Three active components from Chinese herbal medicines induce death of Helicobacter pylori supernatant transformed GES-1 cells , 2007 .

[32]  G. Mahady,et al.  Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. , 2003, Anticancer research.

[33]  G. Mahady,et al.  In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis , 2003, Phytotherapy research : PTR.

[34]  Kong Lingbiao.  Effect of Sihuangtiaowei Decoction and PPI-combination Therapy on Hp-relative Gastritis and Peptic Ulcer Disease , 2003 .

[35]  Huang Suiping.  A Randomized Controlled Trial of Chinese Herbal Medicine for Helicobacter Pylori Associated Chronic Gastritis , 2001 .

[36]  L. Wu,et al.  Rhein affects arylamine N‐acetyltransferase activity in Helicobacter pylori from peptic ulcer patients , 1998, Journal of applied toxicology : JAT.

[37]  J. Chung.  Inhibitory actions of glycyrrhizic acid on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. , 1998, Drug and chemical toxicology.